Bulletin of Experimental Treatments for AIDS (BETA), published by the San Francisco AIDS Foundation, is one of the most comprehensive HIV treatment publications, with hundreds of in-depth articles.

Published in the Bulletin of Experimental Treatments for AIDS Spring 2000 issue, by the San Francisco AIDS Foundation.

Conference Highlights
Main Page

Experimental Drugs

Combination Drug Studies

Drug Interaction Studies

Studies of Switching Therapy

Miscellaneous

BETA
Spring 2000 Table of Contents

Main Page

Contact Us
beta@sfaf.org

Selected Highlights from the 7th CROI -- Miscellaneous

Harvey S. Bartnof, MD

Adherence

Perfect adherence to dosing of HAART for one year led to a viral load undetectability rate of 85% (limit of detection 50 copies/mL) to 100% (limit of detection 400 copies/mL), according to Margaret Fischl, MD, of the University of Miami. All 48 incarcerated, HIV positive persons were required to take every dose under direct observation by personnel at the jail. The HAART regimen included one PI and two NNRTIs. The results underscore the importance of dosing adherence.

International HIV/AIDS

A low-cost plan might slow progression to AIDS in resource-poor countries, according to D. Wolday, MD, of the Armauer Hansen Research Institute in Ethiopia. Dr. Wolday has found that treating intestinal parasites ("deworming") in persons with HIV infection lowered their HIV viral loads. A lower viral load is associated with slower HIV disease progression in the longer term, even though there were no significant differences in CD4 cell counts after six months in this study. Intestinal parasites are very common in many resource-poor countries.

Page last updated 2 June 2000


About AIDS | Treatment | Prevention | Policy | About SFAF | Take Action | Donate
Espaņol | Search | Site Map | Feedback | Email Updates | Home (sfaf.org)